FDA Approves METHADONE HYDROCHLORIDE — Elite Laboratories, Inc.

Elite Laboratories, Inc. announced the approval of the generic Formulation 2 for Methadone Hydrochloride, marking a new commercial entry into the opioid treatment market. This FDA approval, linked to ANDA #210484 and effective August 2, 2018, is anticipated to intensify pricing pressure in the residential opioid agonist therapy segment.